We use cookies to make sure that our website works properly, as well as some optional cookies to personalize content and advertising, provide social media features and analyse how people use our site. Some countries outside of the European Economic Area do not have the same data protection standards as the country where you live, so if you accept some or all optional cookies, you give consent to the processing of your personal data, including transfer to third parties. You can find more information about how your personal data is processed when you click on theManage settings. Further information can be found in our privacy policy.

Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
  • Rahul K. Suryawanshi1 na1,
  • Irene P. Chen  orcid.org/0000-0002-5766-92531,2,3,4 na1,
  • Tongcui Ma1,5 na1,
  • Abdullah M. Syed1,6,
  • Noah Brazer7,
  • Prachi Saldhi7,
  • Camille R. Simoneau  orcid.org/0000-0001-9222-81301,3,4,
  • Alison Ciling1,6,
  • Mir M. Khalid1,
  • Bharath Sreekumar1,
  • Pei-Yi Chen1,
  • G. Renuka Kumar1,
  • Mauricio Montano1,8,
  • Ronne Gascon1,
  • Chia-Lin Tsou1,
  • Miguel A. Garcia-Knight9,
  • Alicia Sotomayor-Gonzalez  orcid.org/0000-0002-8930-745X7,
  • Venice Servellita7,
  • Amelia Gliwa7,
  • Jenny Nguyen7,
  • Ines Silva10,
  • Bilal Milbes10,
  • Noah Kojima10,
  • Victoria Hess10,
  • Maria Shacreaw10,
  • Lauren Lopez10,
  • Matthew Brobeck10,
  • Fred Turner10,
  • Frank W. Soveg1,
  • Ashley F. George1,11,
  • Xiaohui Fang12,
  • Mazharul Maishan  orcid.org/0000-0002-6374-721112,
  • Michael Matthay  orcid.org/0000-0003-3039-815512,
  • Mary Kate Morris13,
  • Debra Wadford13,
  • Carl Hanson13,
  • Warner C. Greene1,3,8,9,
  • Raul Andino  orcid.org/0000-0001-5503-93499,
  • Lee Spraggon10,
  • Nadia R. Roan1,11,
  • Charles Y. Chiu  orcid.org/0000-0003-2915-20943,5,6,7,14,
  • Jennifer A. Doudna  orcid.org/0000-0001-9161-999X1,6,15,16,17,18,19 &
  • Melanie Ott  orcid.org/0000-0002-5697-12741,3,4,14 

This article is about Nature.

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

There are two globally relevant variant of concern. Infections with Delta can lead to lung disease, but Omicron can cause milder symptoms, especially in vaccine recipients. The question is whether widespread Omicron infections could lead to future cross-variant protection. We show that a limited humoral immune response is caused by Omicron infections in mice and humans. The mice that were overexpressing the humanACE2receptor and wereinfecting them with Omicron mitigated only Omicron, but no other VOCs. Omicron replicates to low levels in the lungs and brains of animals that have been bitten, leading to mild disease with reduced pro- inflammatory cytokine expression and diminished activation of lung-resident T cells. The neutralization of only Omicron is shown by the sera from unvaccinated individuals. Omicron breakthrough infections induce higher neutralization titers against all VOCs. Our results show that Omicron can enhance immunity elicited by vaccines, but it may not give broad protection against non-Omicron variants in unvaccinated individuals.

You agree to abide by the Community Guidelines when you submit a comment. If you find something that does not comply with our guidelines, please flag it as inappropriate.